Primary estrogen receptor-positive lung adenocarcinoma identified by immunohistochemical investigation of rare cutaneous metastasis to the breast in a patient with presumed recurrent estrogen receptor-positive breast cancer
Main Authors: | Shu Ting Liang (Amy), BA, Chenin Ryan, MS, Keegan O'Hern, MD, Gabrielle E. Duprat, MD, Sarah A. Donnell, MBBS, Brian Simmons, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512621004239 |
Similar Items
-
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
by: Jharna Datta, et al.
Published: (2022-04-01) -
Estrogen Receptor Signaling in Breast Cancer
by: Paulina Miziak, et al.
Published: (2023-09-01) -
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
by: Suryavathi Viswanadhapalli, et al.
Published: (2019-12-01) -
Estrogen receptor-positive primary squamous cell carcinoma of the breast
by: Abby M. Pribish, BS, et al.
Published: (2017-06-01) -
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
by: Erin R. Scheidemann, et al.
Published: (2021-11-01)